{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:41:27Z","timestamp":1792536087499,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074564"],"award-info":[{"award-number":["82074564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860410"],"award-info":[{"award-number":["81860410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772451"],"award-info":[{"award-number":["81772451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.expneurol.2024.114846","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:50:11Z","timestamp":1718290211000},"page":"114846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antinociceptive role of the thalamic dopamine D3 receptor in descending modulation of intramuscular formalin-induced muscle nociception in a rat model of Parkinson's disease"],"prefix":"10.1016","volume":"379","author":[{"given":"Jing","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Jun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.114846_bb0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2016.03.006","article-title":"Spinal D1-like dopamine receptors modulate NMDA receptor-induced hyperexcitability and NR1 subunit phosphorylation at serine 889","volume":"618","author":"Aira","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2024.114846_bb0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors\u2014IUPHAR review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","article-title":"Pain in Parkinson\u2019s disease: prevalence and characteristics","volume":"141","author":"Beiske","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2024.114846_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(98)00307-4","article-title":"Pramipexole--a new dopamine agonist for the treatment of Parkinson\u2019s disease","volume":"163","author":"Bennett","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0035","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00429-013-0628-1","article-title":"Left hemispheric dominance of vestibular processing indicates lateralization of cortical functions in rats","volume":"219","author":"Best","year":"2014","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.expneurol.2024.114846_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson\u2019s disease","volume":"211","author":"Bov\u00e9","year":"2012","journal-title":"Neuroscience"},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2024.114846_bb0050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-2952(74)90086-0","article-title":"Biochemical and behavioural alterations following 6-hydroxydopamine administration into brain","volume":"23","author":"Breese","year":"1974","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.20629","article-title":"Effect of levodopa on pain threshold in Parkinson\u2019s disease: a clinical and positron emission tomography study","volume":"20","author":"Brefel-Courbon","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2024.114846_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00415-017-8426-y","article-title":"Pain in Parkinson\u2019s disease: a cross-sectional survey of its prevalence, specifics, and therapy","volume":"264","author":"Buhmann","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0065","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.19-10-04169.1999","article-title":"Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception","volume":"19","author":"Burkey","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.expneurol.2019.04.015","article-title":"Monoaminergic regulation of nociceptive circuitry in a Parkinson\u2019s disease rat model","volume":"318","author":"Campos","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0075","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/cmdc.201402398","article-title":"Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability","volume":"9","author":"Chen","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.expneurol.2024.114846_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/j.1532-2149.2012.00207.x","article-title":"Dynamic variations of c-Fos expression in the spinal cord exposed to intramuscular hypertonic saline-induced muscle nociception","volume":"17","author":"Chen","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2024.114846_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/brb3.11","article-title":"A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced parkinsonism of rats","volume":"1","author":"Choudhury","year":"2011","journal-title":"Brain Behav."},{"key":"10.1016\/j.expneurol.2024.114846_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpain.2007.08.008","article-title":"Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat","volume":"12","author":"Coffeen","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2024.114846_bb0095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17460441.2016.1185413","article-title":"Targeting the dopamine D3 receptor: an overview of drug design strategies","volume":"11","author":"Cortes","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.expneurol.2024.114846_bb0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/br.2014.220","article-title":"Polymorphisms of DRD2 and DRD3 genes and Parkinson\u2019s disease: a meta-analysis","volume":"2","author":"Dai","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.expneurol.2024.114846_bb0105","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2024.114846_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2019.02.007","article-title":"Parkinson\u2019s disease and pain: modulation of nociception circuitry in a rat model of nigrostriatal lesion","volume":"315","author":"Domenici","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0115","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.expneurol.2024.114846_bb0120","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/jnnp.2007.120212","article-title":"Levodopa raises objective pain threshold in Parkinson\u2019s disease: a RIII reflex study","volume":"78","author":"Gerdelat-Mas","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2024.114846_bb0125","series-title":"Statistical Quality Control","first-page":"764","author":"Grant","year":"1972"},{"key":"10.1016\/j.expneurol.2024.114846_bb0130","article-title":"The 6-hydroxydopamine rat model of Parkinson\u2019s disease","volume":"176","author":"Guimar\u00e3es","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2024.114846_bb0135","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1517\/14656566.8.16.2799","article-title":"Apomorphine therapy in Parkinson\u2019s disease: a review","volume":"8","author":"Haq","year":"2007","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.expneurol.2024.114846_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2010.05.034","article-title":"Thalamic afferent and efferent connectivity to cerebral cortical areas with direct projections to identified subgroups of trigeminal premotoneurons in the rat","volume":"1346","author":"Haque","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(86)90054-6","article-title":"Projections to the midbrain from the medial versus lateral prefrontal cortices of the rat","volume":"63","author":"Hardy","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2024.114846_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.parkreldis.2015.11.016","article-title":"Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms","volume":"22","author":"Hassan","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2024.114846_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-hydroxydo pamine lesion of the rat substantia nigra: time course and morphology of cell death","volume":"4","author":"Jeon","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2024.114846_bb0165","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cne.901710204","article-title":"The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat","volume":"171","author":"Krettek","year":"1977","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.expneurol.2013.06.001","article-title":"Endogenous descending facilitation and inhibition differ in control of formalin intramuscularly induced persistent muscle nociception","volume":"248","author":"Lei","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2008.07.056","article-title":"Homotopic and heterotopic variation in skin blood flow and temperature following experimental muscle pain in humans","volume":"1232","author":"Lei","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.expneurol.2011.01.004","article-title":"Sex-related differences in descending norepinephrine and serotonin controls of spinal withdrawal reflex during intramuscular saline induced muscle nociception in rats","volume":"228","author":"Lei","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.expneurol.2014.04.019","article-title":"Roles of the periaqueductal gray in descending facilitatory and inhibitory controls of intramuscular hypertonic saline induced muscle nociception","volume":"257","author":"Lei","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2020.02.039","article-title":"Effects of intramuscular heating-needle stimulation in controlling adjuvant-induced muscle nociception in rats: differential roles of thalamic purinergic P2X3 receptors","volume":"433","author":"Lei","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.114846_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuroscience.2020.05.043","article-title":"Effects of heating-needle stimulation in restoration of weakened descending inhibition of nociception in a rat model of Parkinson\u2019s disease","volume":"440","author":"Lei","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.114846_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105646","article-title":"Pathological pain: non-motor manifestations in Parkinson disease and its treatment","volume":"161","author":"Lei","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2024.114846_bb0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0006-8993(98)00529-0","article-title":"Differential distribution of D3 dopamine receptors in the brains of several mammalian species","volume":"800","author":"Levant","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.expneurol.2013.11.015","article-title":"The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesions","volume":"253","author":"Lindgren","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neures.2015.01.006","article-title":"Neural mechanism underlying hyperalgesic response to orofacial pain in Parkinson\u2019s disease model rats","volume":"96","author":"Maegawa","year":"2015","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejphar.2018.07.038","article-title":"Dopaminergic and serotonergic mechanisms in the modulation of pain: in vivo studies in human brain","volume":"834","author":"Martikainen","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(93)90027-M","article-title":"Nociception from skeletal muscle in relation to clinical muscle pain","volume":"54","author":"Mense","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2024.114846_bb0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","article-title":"Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson\u2019s disease model","volume":"122","author":"Miyanishia","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2024.114846_bb0240","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.expneurol.2024.114846_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147887","article-title":"Nucleus accumbens dopamine receptors mediate the stress-induced analgesia in an animal model of acute pain","volume":"1784","author":"Noursadeghi","year":"2022","journal-title":"Brain Res."},{"issue":"1 Suppl 1","key":"10.1016\/j.expneurol.2024.114846_bb0250","first-page":"S17","article-title":"The origin of motor fluctuations in Parkinson\u2019s disease: importance of dopaminergic innervation and basal ganglia circuits","volume":"62","author":"Obeso","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2024.114846_bb0255","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.expneurol.2024.114846_bb0260","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/mds.26826","article-title":"Anatomical and functional correlates of persistent pain in Parkinson\u2019s disease","volume":"31","author":"Polli","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2024.114846_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517726335","article-title":"Abnormalities of dopamine D3 receptor signaling in the diseased brain","volume":"9","author":"Prieto","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.expneurol.2024.114846_bb0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.114846_bb0275","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2024.114846_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108278","article-title":"Ropinirole, a dopamine agonist with high D3 affinity, reduces proactive inhibition: a double-blind, placebo-controlled study in healthy adults","volume":"179","author":"Rawji","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2024.114846_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01250009","article-title":"Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA","volume":"59","author":"Reader","year":"1984","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2024.114846_bb0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113514","article-title":"A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson\u2019s disease","volume":"335","author":"Schneider","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0300","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2015.04.004","article-title":"In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson\u2019s disease","volume":"100","author":"Simms","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2024.114846_bb0305","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0310","first-page":"47","article-title":"The effect of experimental Parkinson on formalin-induced pain in rat","volume":"14","author":"Sofiabadi","year":"2014","journal-title":"J. Ardabil. Univ. Med. Sci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2024.114846_bb0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(97)01078-0","article-title":"D3 dopamine receptor mRNA is widely expressed in the human brain","volume":"779","author":"Suzuki","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1113\/jphysiol.2005.091843","article-title":"Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors","volume":"568","author":"Tamae","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0149-7634(99)00063-9","article-title":"Structure and function of dopamine receptors","volume":"24","author":"Vallone","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2024.114846_bb0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(88)90309-3","article-title":"The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors","volume":"146","author":"Van der Weide","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainresbull.2012.08.002","article-title":"The role of the dopamine D2 receptor in descending control of pain induced by motor cortex stimulation in the neuropathic rat","volume":"89","author":"Viisanen","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2024.114846_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.148128","article-title":"Reduced mechanical hypersensitivity by inhibition of the amygdala in experimental neuropathy: sexually dimorphic contribution of spinal neurotransmitter receptors","volume":"1797","author":"Wei","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114846_bb0350","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","article-title":"Standardization of the rat paw formalin test for the evaluation of analgesics","volume":"104","author":"Wheeler-Aceto","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2024.114846_bb0355","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.mpmed.2016.06.001","article-title":"Parkinson\u2019s disease","volume":"44","author":"Williams-Gray","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.expneurol.2024.114846_bb0360","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bph.12988","article-title":"Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors","volume":"172","author":"Wood","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0365","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14737175.8.5.781","article-title":"Role of central dopamine in pain and analgesia","volume":"8","author":"Wood","year":"2008","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2024.114846_bb0370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2015.07.027","article-title":"Role of thalamic nuclei in the modulation of Fos expression within the cerebral cortex during hypertonic saline-induced muscle nociception","volume":"304","author":"Xiao","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.114846_bb0375","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/acschemneuro.6b00221","article-title":"Functional characterization of a novel series of biased signaling dopamine D3 receptor agonists","volume":"8","author":"Xu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114846_bb0380","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1113\/jphysiol.2010.196923","article-title":"Endogenous descending modulation: spatiotemporal effect of dynamic imbalance between descending facilitation and inhibition of nociception","volume":"588","author":"You","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.021","article-title":"Specific thalamic nuclei function as novel \u2018nociceptive discriminators\u2019 in the endogenous control of nociception in rats","volume":"232","author":"You","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2024.114846_bb0390","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1113\/jphysiol.2014.275800","article-title":"Influence of intramuscular heat stimulation on endogenous modulation of nociception: complex role of central different subtypes of opioid receptors in descending facilitation and inhibition","volume":"592","author":"You","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0395","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1113\/JP271991","article-title":"Pre-emptive analgesia and its supraspinal mechanisms: enhanced descending inhibition and decreased descending facilitation by dexmedetomidine","volume":"594","author":"You","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2024.114846_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104745","article-title":"Thalamus: the \u2018promoter\u2019 of endogenous modulation of pain and potential therapeutic target in pathological pain","volume":"139","author":"You","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2024.114846_bb0405","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2013.57","article-title":"The role of neuroplasticity in dopaminergic therapy for Parkinson disease","volume":"9","author":"Zhuang","year":"2013","journal-title":"Nat. Rev. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:17:41Z","timestamp":1722028661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":81,"alternative-id":["S0014488624001729"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114846","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive role of the thalamic dopamine D3 receptor in descending modulation of intramuscular formalin-induced muscle nociception in a rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114846"}}